novoGI

novoGI is committed to advancing patient care by providing an expanding range of comprehensive solutions for GI disease management. The leadership team is strong and cohesive, bringing to the company deep industry knowledge and multidisciplined expertise. novoGI US headquarters are in Atlanta, Georgia; research, development and manufacturing facili... ties in Netanya, Israel; and its European headquarters are located near Paris, France. Over 10,000 cases have been performed using novoGI's clinically proven, nitinol-based compression anastomosis technology. With more than 50 peer-review publications, clinical results for the novoGI ColonRing substantiate ease of use, healing processes, and successful outcomes in terms of adverse events. Published in the American Journal of Surgery, significant findings of a major 1180-patient analysis include low leak rates of 3.2% overall for end-to-end anastomosis and only 1.9% for low anterior resection (LAR) procedures.Read More